Abrocitinib reverses the altered immune and skin barrier phenotype in skin biopsies from patients with moderate-to-severe atopic dermatitis

被引：0
|
作者：
Del Duca, E. [1 ]
Guttmann-Yassky, E. [1 ]
Da Rosa, Jc [1 ]
Estrada, Y. [1 ]
Kim, M. [1 ]
Facheris, P. [2 ]
Gomez-Arias, Pj [3 ]
Page, K. [4 ]
Guller, E. [5 ]
Xu, D. [6 ]
Chen, A. [7 ]
Chan, G. [7 ]
Kerkmann, U. [8 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY USA
[2] IRCCS Humanitas Res Hosp, Rozzano, Italy
[3] Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba IMIBIC, Cordoba, Spain
[4] Pfizer Inc, Cambridge, MA USA
[5] Pfizer Inc, Istanbul, Turkiye
[6] Pfizer Inc, San Diego, CA USA
[7] Pfizer Inc, Groton, CT USA
[8] Pfizer Pharma GmbH, Berlin, Germany
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
204
引用
收藏
页码：S366 / S366
页数：1
相关论文
共 50 条
  • [1] Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, Emma
    Facheris, Paola
    Gomez-Arias, Pedro Jesus
    Del Duca, Ester
    Da Rosa, Joel Correa
    Weidinger, Stephan
    Bissonnette, Robert
    Armstrong, April W.
    Seneschal, Julien
    Eyerich, Kilian
    Estrada, Yeriel D.
    Bose, Swaroop N.
    Xu, Dan
    Chen, Allshine
    Tatulych, Svitlana
    Guler, Erman
    Chan, Gary
    Page, Karen M.
    Kerkmann, Urs
    [J]. ALLERGY, 2024, 79 (05) : 1258 - 1270
  • [2] Abrocitinib reduces skin pain in adolescent and adult patients with moderate-to-severe atopic dermatitis
    Thyssen, Jacob P.
    Bewley, Anthony
    Staender, Sonja
    Castro, Carla
    Misery, Laurent
    Kim, Brian
    Biswas, Pinaki
    Chan, Gary
    Myers, Daniela E.
    Watkins, Melissa
    Alderfer, Justine
    Guler, Erman
    Silverberg, Jonathan I.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E118 - E118
  • [3] Rapid and sustained improvement in skin pain with abrocitinib in adult and adolescent patients with moderate-to-severe atopic dermatitis
    Thyssen, J. P.
    Bewley, A.
    Stander, S.
    Kim, B.
    Biswas, P.
    DiBonaventura, M.
    Watkins, M.
    Alderfer, J.
    Guler, E.
    Silverberg, J. I.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E150 - E151
  • [4] Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Villegas, Susan C.
    Dima, Lorena
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2023, 30 (02) : E117 - E125
  • [5] An evaluation of abrocitinib for moderate-to-severe atopic dermatitis
    Labib, Angelina
    Yosipovitch, Gil
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (11) : 1107 - 1118
  • [6] Dupilumab Improves Skin Lipid Barrier in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis
    Bronova, Irina
    Berdyshev, Evgeny
    Goleva, Elena
    Danby, Simon
    Bronoff, Anna Sofia
    Richers, Brittany
    Garcia, Shannon
    Gama, Marco Ramirez
    Taylor, Patricia
    Zahn, Joseph
    Agueusop, Inoncent
    Bafna, Shantanu
    Boguniewicz, Mark
    Ong, Peck
    Zhang, Annie
    Cork, Michael
    Leung, Donald
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB5 - AB5
  • [7] Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis
    Berdyshev, Evgeny
    Goleva, Elena
    Bissonnette, Robert
    Bronova, Irina
    Bronoff, Anna Sofia
    Richers, Brittany N.
    Garcia, Shannon
    Ramirez-Gama, Marco
    Taylor, Patricia
    Praestgaard, Amy
    Agueusop, Inoncent
    Jurvilliers, Pauline
    Boguniewicz, Mark
    Levit, Noah A.
    Rossi, Ana B.
    Zhang, Annie
    Leung, Donald Y. M.
    [J]. ALLERGY, 2022, 77 (11) : 3388 - 3397
  • [8] Abrocitinib efficacy and safety in moderate-to-severe atopic dermatitis by race, ethnicity, and Fitzpatrick skin type
    Alexis, Andrew F.
    Silverberg, Jonathan I.
    Rice, Zakiya P.
    Armstrong, April W.
    Desai, Seemal R.
    Fonacier, Luz
    Kabashima, Kenji
    Biswas, Pinaki
    Cella, Ricardo Rojo
    Chan, Gary L.
    Levenberg, Mark
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (03)
  • [9] Abrocitinib: a potential treatment for moderate-to-severe atopic dermatitis
    Nezamololama, Novin
    Crowley, Erika L.
    Gooderham, Melinda J.
    Papp, Kim
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (09) : 911 - 917
  • [10] Immune and barrier characterization of atopic dermatitis skin phenotype in Tanzanian patients
    Lang, Claudia C., V
    Renert-Yuval, Yael
    Del Duca, Ester
    Pavel, Ana B.
    Wu, Jianni
    Zhang, Ning
    Dubin, Celina
    Obi, Ashley
    Chowdhoury, Mashkura
    Kim, Madeline
    Estrada, Yeriel D.
    Krueger, James G.
    Kaderbhai, Hashim
    Semango, George
    Schmid-Grendelmeier, Peter
    Bruggen, Marie-Charlotte
    Masenga, John E.
    Guttman-Yassky, Emma
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (03) : 334 - 341
12345